InvestorsHub Logo
Followers 30
Posts 5248
Boards Moderated 0
Alias Born 10/16/2012

Re: The Other Guy post# 1640

Thursday, 02/26/2015 10:40:48 AM

Thursday, February 26, 2015 10:40:48 AM

Post# of 5006
Okay, so I spent a bit of time doing some DD. Found this in the RXI Q&A:

In addition, the combined market potential for all three indications for which DPCP is used today is greater than $1 Billion, with warts being the major market. Aldara (Imiquimod) and Picato are the primary competitors in this space. Together these benefits may potentially result in financially rewarding partnerships and licensing deals.



If RXI gains merely a double digit percentage of the market share, RXII multiplies substantially.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News